New hope for young AML patients: targeted drug combo tested in phase 2 trial
NCT ID NCT06917911
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 39 times
Summary
This study tests two different drug combinations for younger adults with a specific type of acute myeloid leukemia (CBF-AML). One group gets standard chemotherapy plus a targeted antibody, while the other gets the same chemotherapy plus a newer targeted pill. The goal is to see which combination works better at clearing the cancer with fewer side effects. About 162 people will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baptist Cancer Center-Grenada
RECRUITINGGrenada, Mississippi, 38901, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Baptist Memorial Hospital and Cancer Center-Collierville
RECRUITINGCollierville, Tennessee, 38017, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Baptist Memorial Hospital and Cancer Center-Desoto
RECRUITINGSouthhaven, Mississippi, 38671, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Baptist Memorial Hospital and Cancer Center-Golden Triangle
RECRUITINGColumbus, Mississippi, 39705, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Baptist Memorial Hospital and Cancer Center-Memphis
RECRUITINGMemphis, Tennessee, 38120, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Baptist Memorial Hospital and Cancer Center-Oxford
RECRUITINGOxford, Mississippi, 38655, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Baptist Memorial Hospital and Cancer Center-Union County
RECRUITINGNew Albany, Mississippi, 38652, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Gundersen Lutheran Medical Center
RECRUITINGLa Crosse, Wisconsin, 54601, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Trinity Health IHA Medical Group Hematology Oncology - Brighton
RECRUITINGBrighton, Michigan, 48114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Trinity Health IHA Medical Group Hematology Oncology - Canton
RECRUITINGCanton, Michigan, 48188, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
RECRUITINGChelsea, Michigan, 48118, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
RECRUITINGYpsilanti, Michigan, 48197, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Trinity Health Saint Joseph Mercy Oakland Hospital
RECRUITINGPontiac, Michigan, 48341, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Trinity Health Saint Mary Mercy Livonia Hospital
RECRUITINGLivonia, Michigan, 48154, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.